Insiders ProQR Therapeutics N.V.

Equities

PRQR

NL0010872495

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
2 ^USD	0.00%		+0.50%	+1.01%

05-09	ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-08	ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer? RNA Editing Program Targeting NTCP for Cholestatic Diseases	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProQR Therapeutics N.V. Announces Stepping Down of Dinko Valerio as Chairperson	04-22	CI
ProQR Therapeutics N.V. Approves the Appointment of Theresa Heggie and Begoña Carreño as Supervisory Board Member	23-05-17	CI
ProQR Therapeutics N.V. Appoints Jurriaan Dekkers as Chief Financial Officer	22-11-09	CI
ProQR Therapeutics N.V. Appoints Rene Beukema as Member of Management Board	22-06-30	CI
ProQR Therapeutics Says CFO to Depart at End of 2022	22-06-01	MT
ProQR Therapeutics N.V. Announces Executive Changes	22-06-01	CI
ProQR Therapeutics N.V. Announces Resignation of Smital Shah as Chief Financial Officer	22-06-01	CI
ProQR Therapeutics N.V. Appoints John Maraganore as Strategic Advisor to the Supervisory Board	22-03-07	CI
ProQR Therapeutics N.V. Appoints Theresa Heggie as Chief Commercial Officer	21-10-04	CI
ProQR Therapeutics N.V. Appoints Naveed Shams as Chief Scientific Officer	20-10-05	CI
ProQR Therapeutics N.V. Announces Management Changes	18-12-13	CI
ProQR Therapeutics N.V. Appoints Yi-Tao Yu to the Scientific Advisory Board	18-05-23	CI
ProQR Therapeutics N.V. Appoints Dr. Peter A. Beal to Scientific Advisory Board	18-04-10	CI
ProQR Therapeutics N.V. Appoints Thaddeus Dryja to Scientific Advisory Board	17-11-09	CI
ProQR Therapeutics N.V. Announces Management Change and Key Promotions	17-10-26	CI
ProQR Therapeutics N.V Announces Executive Appointments	17-08-28	CI
ProQR Therapeutics N.V. Announces Demise of its Co-Founder and Supervisory Board Member, Henri A. Termeer	17-05-15	CI
ProQR Therapeutics Names David Rodman as Chief Development Strategy Officer	17-03-27	CI
ProQR Therapeutics N.V. Approves the Appointment of Paul Baart as a New Member of the Supervisory Board	15-06-11	CI
ProQR Therapeutics N.V. Appoints Smital Shah as Chief Financial Officer	14-10-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ProQR Therapeutics N.V.

Equities

PRQR

NL0010872495

Insiders

Filters